Stericycle (NASDAQ:SRCL) Coverage Initiated by Analysts at StockNews.com

Stock analysts at StockNews.com started coverage on shares of Stericycle (NASDAQ:SRCLGet Free Report) in a research report issued to clients and investors on Monday. The brokerage set a “hold” rating on the business services provider’s stock.

Stericycle Stock Performance

SRCL stock opened at $61.98 on Monday. The company has a market capitalization of $5.75 billion, a P/E ratio of 163.11, a PEG ratio of 3.36 and a beta of 1.10. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 0.55. The company has a 50-day simple moving average of $60.82 and a 200 day simple moving average of $56.76. Stericycle has a fifty-two week low of $37.78 and a fifty-two week high of $61.99.

Institutional Investors Weigh In On Stericycle

Several hedge funds and other institutional investors have recently added to or reduced their stakes in SRCL. Capital Research Global Investors raised its stake in shares of Stericycle by 11.4% in the 1st quarter. Capital Research Global Investors now owns 6,667,911 shares of the business services provider’s stock worth $351,732,000 after buying an additional 679,974 shares in the last quarter. Earnest Partners LLC lifted its holdings in Stericycle by 12.4% in the 1st quarter. Earnest Partners LLC now owns 2,460,020 shares of the business services provider’s stock valued at $129,766,000 after acquiring an additional 271,025 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in shares of Stericycle by 7.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 2,171,659 shares of the business services provider’s stock valued at $126,238,000 after purchasing an additional 142,814 shares in the last quarter. Pentwater Capital Management LP acquired a new position in shares of Stericycle in the 2nd quarter worth approximately $83,010,000. Finally, Magnetar Financial LLC bought a new stake in shares of Stericycle in the 2nd quarter worth approximately $81,596,000. Institutional investors own 98.82% of the company’s stock.

About Stericycle

(Get Free Report)

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.

Recommended Stories

Analyst Recommendations for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.